Cytocom: Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

Cytocom, Inc., a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced that the audio archive of the second quarter 2021 corporate and financial results conference call may be accessed from the "Investors" section of the Cytocom website at https://www.cytocom.com/investors/.